243 related articles for article (PubMed ID: 17324159)
1. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.
Mazur I; Wurzer WJ; Ehrhardt C; Pleschka S; Puthavathana P; Silberzahn T; Wolff T; Planz O; Ludwig S
Cell Microbiol; 2007 Jul; 9(7):1683-94. PubMed ID: 17324159
[TBL] [Abstract][Full Text] [Related]
2. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
[TBL] [Abstract][Full Text] [Related]
3. The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance.
Ehrhardt C; Rückle A; Hrincius ER; Haasbach E; Anhlan D; Ahmann K; Banning C; Reiling SJ; Kühn J; Strobl S; Vitt D; Leban J; Planz O; Ludwig S
Cell Microbiol; 2013 Jul; 15(7):1198-211. PubMed ID: 23320394
[TBL] [Abstract][Full Text] [Related]
4. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
Ehrhardt C; Hrincius ER; Korte V; Mazur I; Droebner K; Poetter A; Dreschers S; Schmolke M; Planz O; Ludwig S
Antiviral Res; 2007 Oct; 76(1):38-47. PubMed ID: 17572513
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
6. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.
Ludwig S
J Antimicrob Chemother; 2009 Jul; 64(1):1-4. PubMed ID: 19420020
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.
Conti G; Magliani W; Conti S; Nencioni L; Sgarbanti R; Palamara AT; Polonelli L
Antimicrob Agents Chemother; 2008 Dec; 52(12):4331-7. PubMed ID: 18824612
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.
Geiler J; Michaelis M; Naczk P; Leutz A; Langer K; Doerr HW; Cinatl J
Biochem Pharmacol; 2010 Feb; 79(3):413-20. PubMed ID: 19732754
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.
Pinto R; Herold S; Cakarova L; Hoegner K; Lohmeyer J; Planz O; Pleschka S
Antiviral Res; 2011 Oct; 92(1):45-56. PubMed ID: 21641936
[TBL] [Abstract][Full Text] [Related]
10. Infection of human retinal pigment epithelial cells with influenza A viruses.
Michaelis M; Geiler J; Klassert D; Doerr HW; Cinatl J
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5419-25. PubMed ID: 19553611
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.
Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ
Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.
Murray JL; McDonald NJ; Sheng J; Shaw MW; Hodge TW; Rubin DH; O'Brien WA; Smee DF
Antivir Chem Chemother; 2012 May; 22(5):205-15. PubMed ID: 22374988
[TBL] [Abstract][Full Text] [Related]
13. Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy.
Ludwig S; Planz O
Biol Chem; 2008 Oct; 389(10):1307-12. PubMed ID: 18713017
[TBL] [Abstract][Full Text] [Related]
14. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
Nacken W; Ehrhardt C; Ludwig S
Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
[TBL] [Abstract][Full Text] [Related]
15. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
16. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
[TBL] [Abstract][Full Text] [Related]
17. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
Duwe S; Schweiger B
J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
[TBL] [Abstract][Full Text] [Related]
18. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
19. Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza.
Zhao H; To KKW; Chu H; Ding Q; Zhao X; Li C; Shuai H; Yuan S; Zhou J; Kok KH; Jiang S; Yuen KY
Nat Commun; 2018 Jun; 9(1):2358. PubMed ID: 29907765
[TBL] [Abstract][Full Text] [Related]
20. Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-κB signal pathways.
Wang QW; Su Y; Sheng JT; Gu LM; Zhao Y; Chen XX; Chen C; Li WZ; Li KS; Dai JP
PLoS One; 2018; 13(1):e0191793. PubMed ID: 29385192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
